Clinical Trials Logo

Filter by:
NCT ID: NCT05633862 Completed - Healthy Clinical Trials

A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body

Start date: January 13, 2023
Phase: Phase 1
Study type: Interventional

The main objectives of this trial are to investigate pharmacokinetics, safety and tolerability of BI 1015550 in Chinese healthy male and female subjects following administration of single doses.

NCT ID: NCT05633732 Recruiting - Echocardiography Clinical Trials

Developing Echocardiography Image Quality Management System Based on Deep Learning

Start date: December 30, 2022
Phase:
Study type: Observational

To develop an echocardiography image quality management system based on deep learning to achieve objective and accurate automatic echocardiography image quality control. A total of 2000 patients performing transthoracic echocardiography were prospectively enrolled in the Department of Ultrasound Medicine of the Affiliated Drum Tower Hospital with Medical School of Nanjing University. The data of 8 TTE view segmentations were collected, including the views of the parasternal long axis of the left ventricle (PLAX_LV), parasternal short axis of the large vessel level (PSAX_GV), parasternal short axis of the mitral valve level (PSAX_MV), parasternal short axis of the papillary muscle level (PSAX_PM), parasternal short axis of the apical level (PSAX_AP), apical four cavity (A4C), apical three cavity (A3C), apical two cavity (A2C). The data of 1500 patients were used as the training set, and the rest were used as the validation set. These video data were classified into corresponding view segmentations and analyzed by the Video Swin Transformed Model. Then, the scoring module of different view segmentations combined key frame extraction, image segmentation, video target recognition and video classification model were established. At the same time, the scores achieved by the automatic echocardiography image assessment system were compared with the artificial score. By constantly correcting and learning and eventually building an primary automated grading system. At last, the automatic echocardiography image assessment system was constructed and performed on the rest 500 patients.

NCT ID: NCT05633680 Active, not recruiting - Breast Neoplasm Clinical Trials

Circulating Tumor Cells Screen for Breast Cancer

CTCSFBC
Start date: February 20, 2020
Phase:
Study type: Observational [Patient Registry]

A prospective study was used to collect patients considering breast cancer admitted to our general surgery department from 2019-6 to 2023-8, to identify the case group (breast cancer) and the control group (non-breast cancer), to compare the differences in CTC in peripheral blood between the two groups, and to draw conclusions after statistical analysis.

NCT ID: NCT05633641 Recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell Carcinoma

Start date: October 19, 2022
Phase:
Study type: Observational

This is a single-center clinical and exploratory study. Peripheral blood tumor antigen-specific T lymphocytes of patients with resectable esophageal cancer treated with neoadjuvant chemotherapy combined with immunotherapy and patients with advanced or metastatic esophageal cancer treated with first-line chemotherapy were detected at different time points to predict ORR after neoadjuvant chemotherapy combined with immunotherapy for resectable esophageal cancer and pCR rate, DFS after radical resection and first-line metastasis of advanced esophageal cancer Therapy combined with immunotherapy for ORR, PFS and OS.

NCT ID: NCT05633524 Completed - Sjögren's Syndrome Clinical Trials

HRR as a Novel Biomarker in Sjögren's Syndrome

Start date: October 29, 2020
Phase:
Study type: Observational

Sjögren's syndrome (SS) is an autoimmune disorder characterized by chronic salivary and lacrimal gland dysfunction leading to dry mouth (xerostomia) and dry eye (xerophthalmia) sensation (1). Although dry mouth and dry eye are the main symptoms, the disease may influence many organs and systems. Diagnosis is made with ocular surface staining scores, anti-SS-A/SS-B auto-antibody positivity, and minor salivary gland biopsy (2). The Complete blood count (CBC) is a simple, inexpensive, accessible, and routinely used laboratory parameter that can be linked to oxidative stress, inflammation and microvascular flow resistance. Parameters include NLR and PLR values may be calculated by using CBC parameters (3). Neutrophil/lymphocyte ratio is used as an inflammatory marker in the diagnosis and prognosis of many cardiovascular diseases, malignancies, and infections (4-6). Peripheral inflammatory biomarkers of hematologic indices had been suggested by numerous studies to play a role during SS onset and progression.

NCT ID: NCT05633212 Recruiting - Clinical trials for Binocular Vision Disorder

Binocular Vision Alternations and fMRI Activation After ICL Implantation for High Myopia

Start date: March 15, 2022
Phase:
Study type: Observational

Implantable collamer lens (ICL) is one of the most effective operation for high myopia. Due to refractive correction changed, and prism effect of the spectacle removed, in the early stage after ICL implantation, binocular function might be dysfunction, leading to asthenopia, blurred vision, double vision and so on. This study will recruit the high myopia subjects that scheduled for ICL implantation, purpose to investigate the binocular vision alternations and brain activation that impacted by ICL implantation.

NCT ID: NCT05633199 Not yet recruiting - Clinical trials for Cytoreductive Surgery

Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

This novel study was specifically designed for platinum-resistant recurrent ovarian cancers with PFI<6 months and aimed to compare prognosis of patients who received cytoreductive surgery followed by chemotherapy versus chemotherapy alone.

NCT ID: NCT05632939 Recruiting - Gastric Cancer Clinical Trials

ASKB589 in Combination With CAPOX and Sintilimab in Patients With Advanced, and Unresectable G/GEJ Cancer.

Start date: February 10, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This was an open-label, phase 1/2 study to evaluate safety, tolerability, pharmacokinetics, and antitumor activity of ASKB589 in combination with CAPOX and Sintilimab in first-line treatment of patients with locally advanced, recurrent, or metastatic gastric and esophagogastric junction adenocarcinoma.

NCT ID: NCT05632861 Recruiting - NASH Clinical Trials

HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

Start date: February 21, 2023
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy and safety and the best effective dose of HuHuangLianzonggan capsule in subjects with nonalcoholic steatohepatitis.

NCT ID: NCT05632848 Recruiting - Clinical trials for Triple Negative Breast Cancer

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

Start date: June 15, 2022
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of a new treatment regimen (Chidamide combined with Zimberelimab) in the treatment of patients with metastatic triple negative breast cancer after the second-line therapy.